一个72岁男性患者以不稳定心绞痛收入。
A 72-year-old man with unstable angina was admitted to the hospital.
这是我做过的最满意的不稳定心绞痛动物模型。
This to me is still the best animal model of unstable angina pectoris.
目的：探明辛伐他汀在不稳定心绞痛治疗中的有益作用。
Objective: To verify the beneficial effect of simvastatin in the treatment of the unstable angina.
目的观察欣康与异舒吉治疗不稳定心绞痛的临床疗效及不良反应。
Objective To observe the clinical effect on angina with Xinkang and Yishuji drugs.
目的观察灯盏花素对老年不稳定心绞痛的临床疗效和血液生化指标的影响。
Objective to observe the influences of Breviscapine injection on the clinical therapeutic effect and hemorrheology in treating aged patients of unstable angina pectoris (UAP).
结论：复方丹参滴丸治疗不稳定心绞痛短期疗效好，且不良反应少，耐受性好。
Conclusion: Compound Danshen dropping pill was affirmed on angina treatment, the effect of short damage and with less adverse reaction and good tolerance.
的翻译是：它表明，茶的好处可能有助于临床的不稳定心绞痛和减少qt间隔分布。
It indicates that TEA may contribute to clinical benefits of unstable angina pectoris and reduction of Q t interval dispersion.
结论注射用灯盏花素是一种治疗不稳定心绞痛的有效药物，可抑制不稳定心绞痛的发作。
Conclusion Breviscapine injection is a kind of effective drug in treating patients of UAP, so it could inhibit the break out of UAP.
结论：辛伐他汀在不稳定心绞痛治疗中，起着肯定的有益作用，并且早期应用可能即获益。
Conclusion: Simvastatin reveals the definite beneficial effect in treating the unstable angina and may get it in the early use.
方法采用化湿泄浊汤治疗不稳定心绞痛，疗程为12周，分别于治疗前后检测Hs - CRP一次。
Methods HSXZ Decoction was administered to the patients with unstable angina pectoris for 12 weeks. Hs-CRP was detected before and after the administration.
方法采用化湿泄浊汤治疗不稳定心绞痛，疗程为12周，分别于治疗前后检测Hs - CRP一次。
Methods HSXZ Decoction was administered to the patients with unstable angina pectoris for 12 weeks.
排除患有不稳定心绞痛、近期发生心肌梗塞或急性心力衰竭的患者以及左心室射血分数<40%的患者。
Patients with unstable angina, a recent history of MI or acute heart failure, or an LVEF <40% were excluded.
发生稳定心绞痛、不稳定心绞痛的患者均有减少趋势(未达统计学显著性)，未出现急性心肌梗塞患者。
Patients of stable angina pectoris and unstable angina pectoris tend to decrease (didn't reach statistical significance), no acute myocardial patients occurred.
目的：探讨心肌梗死溶栓疗法（TIMI）危险评分在不稳定心绞痛（UA）患者危险分层及预后预测中的作用。
Objective:To investigate the role of TIMI risk score in risk stratification and predicting outcomes in patients with unstable angina.
波立维通过不使血小板造成凝血而降低心脏病发作，不稳定心绞痛，脑卒中，和心血管疾病患者的心血管死亡的风险。
Plavix reduces the risk of heart attack, unstable angina, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots.
目的本研究评价直接支架术在急性心肌梗死和不稳定心绞痛患者中应用的成功率、病变选择特征及并发症的发生情况。
AIM To compare the effect of direct stenting (DS) and conventional post-dilation stenting (CS) on no-reflow phenomena in patients with coronary artery disease (CAD).
结果表明：治疗组对不稳定心绞痛临床疗效达90.0％，与对照组疗效56.6％比较差异有高度显著性（P<0.01）；
The results indicated that the clinical therapeutic effect in treatment group is 90%, obviously no-table(P<0. 01) in compare with control group's 56. 6%.
结论：组织因子途径抑制物作为组织因子途径凝血过程的抑制物，间接反应了不稳定心绞痛发作过程中血管内皮的损伤和凝血状态。
CONCLUSION: TFPI acted as an inhibitor of tissue factor pathway reflected the vascular endothelial injury and the states of coagulation indirectly in unstable angina progression.
前言： 目的：观察西药联合中药康心胶囊治疗冠心病不稳定心绞痛的疗效。方法：对照组30例用消心痛、 肠溶阿斯匹林治疗；
Objective:To observe the effect of Western drugs combined with traditional Chinese drug, KangXi capsule in treating unstable angina of coronary heart disease.
急性冠脉综合征(ACS)包括不稳定心绞痛(UA)、非st段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)。
Acute coronary syndrome (ACS) includes unstable angina (UA), non-ST segment elevated myocardial infarction (NSTEMI) and st segment elevated myocardial infarction (STEMI).
急性冠脉综合征(ACS)包括不稳定心绞痛(UA)、非st段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)。
Acute coronary syndrome (ACS) includes unstable angina (UA), non-ST segment elevated myocardial infarction (NSTEMI) and st segment elevated myocardial infarction (STEMI).
应用推荐